5Nathan D M, Buse J B, Davidson M B, et al.Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy[J].Diabetologia, 2008, 16(51):8-11.
6Marshall SM. Recent advances in diabetic nephropathy[J].Clinical Medicine,2004,(03):277-282.
7Yilmaz N,Cicek HK,Celik A. Diagnostic value of homocysteine,C-reactive protein and bilirubin for coronary artery disease[J].Eastern Mediterranean Health Journal,2007,(03):522-535.
8UK Prospective Diabetes Study(UKPDS)Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33)[J].The Lancet,1998,(9131):837-853.doi:10.1016/S0140-6736(98)07019-6.
9Hoogeveen EK,Kostense PJ,Jager A. Serum homocysteine level and protein intake are related to risk of microalbuminuria:the Hoorn study[J].Kidney International,1998,(01):203-209.
10Ozmen B,Ozmen D,Turgan N. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus[J].Annals of Clinical and Laboratory Science,2002,(03):279-286.
